{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:35:45Z","timestamp":1792683345990,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10875-020-00790-x","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T02:02:30Z","timestamp":1590458550000},"page":"671-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["An Update on XMEN Disease"],"prefix":"10.1007","volume":"40","author":[{"given":"Juan C.","family":"Ravell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel D.","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lenardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"issue":"7357","key":"790_CR1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature10246","volume":"475","author":"FY Li","year":"2011","unstructured":"Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature. 2011;475(7357):471\u20136.","journal-title":"Nature"},{"issue":"6142","key":"790_CR2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1240094","volume":"341","author":"B Chaigne-Delalande","year":"2013","unstructured":"Chaigne-Delalande B, Li FY, O'Connor GM, Lukacs MJ, Jiang P, Zheng L, et al. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science. 2013;341(6142):186\u201391.","journal-title":"Science"},{"issue":"14","key":"790_CR3","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1182\/blood-2013-11-538686","volume":"123","author":"FY Li","year":"2014","unstructured":"Li FY, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo MJ. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood. 2014;123(14):2148\u201352.","journal-title":"Blood"},{"issue":"1","key":"790_CR4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI131116","volume":"130","author":"JC Ravell","year":"2020","unstructured":"Ravell JC, Matsuda-Lennikov M, Chauvin SD, Zou J, Biancalana M, Deeb SJ, et al. Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease. J Clin Invest. 2020;130(1):507\u201322.","journal-title":"J Clin Invest"},{"issue":"2","key":"790_CR5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10875-014-0116-2","volume":"35","author":"F Dhalla","year":"2015","unstructured":"Dhalla F, Murray S, Sadler R, Chaigne-Delalande B, Sadaoka T, Soilleux E, et al. Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease. J Clin Immunol. 2015;35(2):112\u20138.","journal-title":"J Clin Immunol"},{"issue":"1","key":"790_CR6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10875-016-0341-y","volume":"37","author":"I Brigida","year":"2017","unstructured":"Brigida I, Chiriaco M, di Cesare S, Cittaro D, di Matteo G, Giannelli S, et al. Large deletion of MAGT1 gene in a patient with classic Kaposi sarcoma, CD4 Lymphopenia, and EBV infection. J Clin Immunol. 2017;37(1):32\u20135.","journal-title":"J Clin Immunol"},{"issue":"1","key":"790_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2015.04.015","volume":"159","author":"T Patiroglu","year":"2015","unstructured":"Patiroglu T, Haluk Akar H, Gilmour K, Unal E, Akif Ozdemir M, Bibi S, et al. A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease. Clin Immunol. 2015;159(1):58\u201362.","journal-title":"Clin Immunol"},{"issue":"1","key":"790_CR8","first-page":"48","volume":"56","author":"TY He","year":"2018","unstructured":"He TY, Xia Y, Li CG, Li CR, Qi ZX, Yang J. X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia: report of a family and literature review. Zhonghua Er Ke Za Zhi. 2018;56(1):48\u201352.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"1","key":"790_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5114\/ceji.2015.56168","volume":"41","author":"HH Akar","year":"2016","unstructured":"Akar HH, Patiroglu T, Hershfield M, van der Burg M. Combined immunodeficiencies: twenty years experience from a single center in Turkey. Cent Eur J Immunol. 2016;41(1):107\u201315.","journal-title":"Cent Eur J Immunol"},{"issue":"1","key":"790_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-018-0573-0","volume":"39","author":"D Dimitrova","year":"2019","unstructured":"Dimitrova D, Rose JJ, Uzel G, Cohen JI, Rao KV, Bleesing JH, et al. Successful bone marrow transplantation for XMEN: hemorrhagic risk uncovered. J Clin Immunol. 2019;39(1):1\u20133.","journal-title":"J Clin Immunol"},{"issue":"20","key":"790_CR11","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1073\/pnas.1817815116","volume":"116","author":"E Blommaert","year":"2019","unstructured":"Blommaert E, P\u00e9anne R, Cherepanova NA, Rymen D, Staels F, Jaeken J, et al. Mutations in MAGT1 lead to a glycosylation disorder with a variable phenotype. Proc Natl Acad Sci U S A. 2019;116(20):9865\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"790_CR12","doi-asserted-by":"crossref","unstructured":"Klinken EM, et al. Diversity of XMEN disease: description of 2 novel variants and analysis of the lymphocyte phenotype. J Clin Immunol. 2019.","DOI":"10.1007\/s10875-019-00732-2"},{"key":"790_CR13","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1074\/jbc.RA119.008903","volume":"294","author":"M Matsuda-Lennikov","year":"2019","unstructured":"Matsuda-Lennikov M, Biancalana M, Zou J, Ravell JC, Zheng L, Kanellopoulou C, et al. Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genes. J Biol Chem. 2019;294:13638\u201356.","journal-title":"J Biol Chem"},{"issue":"3","key":"790_CR14","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1684\/mrh.2011.0286","volume":"24","author":"FY Li","year":"2011","unstructured":"Li FY, Lenardo MJ, Chaigne-Delalande B. Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency. Magnes Res. 2011;24(3):S109\u201314.","journal-title":"Magnes Res"},{"key":"790_CR15","doi-asserted-by":"crossref","unstructured":"Hoyos-Bachiloglu R, et al. The many faces of XMEN disease, report of two patients with novel mutations. J Clin Immunol. 2020.","DOI":"10.1007\/s10875-020-00746-1"},{"issue":"1","key":"790_CR16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.abb.2006.07.012","volume":"458","author":"A Romani","year":"2007","unstructured":"Romani A. Regulation of magnesium homeostasis and transport in mammalian cells. Arch Biochem Biophys. 2007;458(1):90\u2013102.","journal-title":"Arch Biochem Biophys"},{"key":"790_CR17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2164-6-48","volume":"6","author":"A Goytain","year":"2005","unstructured":"Goytain A, Quamme GA. Identification and characterization of a novel mammalian Mg2+ transporter with channel-like properties. BMC Genomics. 2005;6:48.","journal-title":"BMC Genomics"},{"issue":"37","key":"790_CR18","doi-asserted-by":"crossref","first-page":"15750","DOI":"10.1073\/pnas.0908332106","volume":"106","author":"H Zhou","year":"2009","unstructured":"Zhou H, Clapham DE. Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development. Proc Natl Acad Sci U S A. 2009;106(37):15750\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"790_CR19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.str.2014.02.013","volume":"22","author":"E Mohorko","year":"2014","unstructured":"Mohorko E, Owen RL, Maloj\u010di\u0107 G, Brozzo MS, Aebi M, Glockshuber R. Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33\/Tusc3 and its role in regulating protein N-glycosylation. Structure. 2014;22(4):590\u2013601.","journal-title":"Structure"},{"issue":"27","key":"790_CR20","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1073\/pnas.0812515106","volume":"106","author":"BL Schulz","year":"2009","unstructured":"Schulz BL, Stirnimann CU, Grimshaw JPA, Brozzo MS, Fritsch F, Mohorko E, et al. Oxidoreductase activity of oligosaccharyltransferase subunits Ost3p and Ost6p defines site-specific glycosylation efficiency. Proc Natl Acad Sci U S A. 2009;106(27):11061\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"790_CR21","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.febslet.2011.05.052","volume":"585","author":"F Deason-Towne","year":"2011","unstructured":"Deason-Towne F, Perraud AL, Schmitz C. The Mg2+ transporter MagT1 partially rescues cell growth and Mg2+ uptake in cells lacking the channel-kinase TRPM7. FEBS Lett. 2011;585(14):2275\u20138.","journal-title":"FEBS Lett"},{"issue":"1","key":"790_CR22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0304-4165(99)00165-8","volume":"1473","author":"R Apweiler","year":"1999","unstructured":"Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta. 1999;1473(1):4\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"790_CR23","doi-asserted-by":"crossref","unstructured":"Pascoal C, et al. CDG and immune response: from bedside to bench and back. J Inherit Metab Dis. 2019.","DOI":"10.1002\/jimd.12126"},{"issue":"1","key":"790_CR24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.bi.54.070185.003215","volume":"54","author":"R Kornfeld","year":"1985","unstructured":"Kornfeld R, Kornfeld S. ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES. Annu Rev Biochem. 1985;54(1):631\u201364.","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"790_CR25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.sbi.2011.08.005","volume":"21","author":"F Schwarz","year":"2011","unstructured":"Schwarz F, Aebi M. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol. 2011;21(5):576\u201382.","journal-title":"Curr Opin Struct Biol"},{"key":"790_CR26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcdb.2014.11.005","volume":"41","author":"S Shrimal","year":"2015","unstructured":"Shrimal S, Cherepanova NA, Gilmore R. Cotranslational and posttranslocational N-glycosylation of proteins in the endoplasmic reticulum. Semin Cell Dev Biol. 2015;41:71\u20138.","journal-title":"Semin Cell Dev Biol"},{"key":"790_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ceb.2016.03.021","volume":"41","author":"N Cherepanova","year":"2016","unstructured":"Cherepanova N, Shrimal S, Gilmore R. N-linked glycosylation and homeostasis of the endoplasmic reticulum. Curr Opin Cell Biol. 2016;41:57\u201365.","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"790_CR28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1083\/jcb.201404083","volume":"206","author":"NA Cherepanova","year":"2014","unstructured":"Cherepanova NA, Shrimal S, Gilmore R. Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins. J Cell Biol. 2014;206(4):525\u201339.","journal-title":"J Cell Biol"},{"issue":"8","key":"790_CR29","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1083\/jcb.201904004","volume":"218","author":"NA Cherepanova","year":"2019","unstructured":"Cherepanova NA, Venev SV, Leszyk JD, Shaffer SA, Gilmore R. Quantitative glycoproteomics reveals new classes of STT3A- and STT3B-dependent N-glycosylation sites. J Cell Biol. 2019;218(8):2782\u201396.","journal-title":"J Cell Biol"},{"issue":"1","key":"790_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1097-2765(03)00243-0","volume":"12","author":"DJ Kelleher","year":"2003","unstructured":"Kelleher DJ, Karaoglu D, Mandon EC, Gilmore R. Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties. Mol Cell. 2003;12(1):101\u201311.","journal-title":"Mol Cell"},{"issue":"14","key":"790_CR31","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.92.14.6229","volume":"92","author":"W Chen","year":"1995","unstructured":"Chen W, Helenius J, Braakman I, Helenius A. Cotranslational folding and calnexin binding during glycoprotein synthesis. Proc Natl Acad Sci. 1995;92(14):6229\u201333.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"790_CR32","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1074\/jbc.271.11.6241","volume":"271","author":"P Whitley","year":"1996","unstructured":"Whitley P, Nilsson I, von Heijne G. A nascent secretory protein 5 traverse the ribosome\/endoplasmic reticulum Translocase complex as an extended chain. J Biol Chem. 1996;271(11):6241\u20134.","journal-title":"J Biol Chem"},{"issue":"6","key":"790_CR33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tig.2018.03.002","volume":"34","author":"BG Ng","year":"2018","unstructured":"Ng BG, Freeze HH. Perspectives on glycosylation and its congenital disorders. Trends Genet. 2018;34(6):466\u201376.","journal-title":"Trends Genet"},{"issue":"1","key":"790_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2018.11.003","volume":"126","author":"R Francisco","year":"2019","unstructured":"Francisco R, Marques-da-Silva D, Brasil S, Pascoal C, dos Reis Ferreira V, Morava E, et al. The challenge of CDG diagnosis. Mol Genet Metab. 2019;126(1):1\u20135.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"790_CR35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2016.12.014","volume":"120","author":"A Al Teneiji","year":"2017","unstructured":"Al Teneiji A, et al. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II. Mol Genet Metab. 2017;120(3):235\u201342.","journal-title":"Mol Genet Metab"},{"key":"790_CR36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.genom.8.080706.092327","volume":"8","author":"J Jaeken","year":"2007","unstructured":"Jaeken J, Matthijs G. Congenital disorders of glycosylation: a rapidly expanding disease family. Annu Rev Genomics Hum Genet. 2007;8:261\u201378.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"4","key":"790_CR37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/156652407780831548","volume":"7","author":"HH Freeze","year":"2007","unstructured":"Freeze HH. Congenital disorders of glycosylation: CDG-I, CDG-II, and beyond. Curr Mol Med. 2007;7(4):389\u201396.","journal-title":"Curr Mol Med"},{"issue":"6","key":"790_CR38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","volume":"370","author":"LC Tegtmeyer","year":"2014","unstructured":"Tegtmeyer LC, Rust S, van Scherpenzeel M, Ng BG, Losfeld ME, Timal S, et al. Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med. 2014;370(6):533\u201342.","journal-title":"N Engl J Med"},{"issue":"5","key":"790_CR39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1203\/00006450-200211000-00003","volume":"52","author":"S Gr\u00fcnewald","year":"2002","unstructured":"Gr\u00fcnewald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: a review. Pediatr Res. 2002;52(5):618\u201324.","journal-title":"Pediatr Res"},{"issue":"1","key":"790_CR40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4049\/jimmunol.1701133","volume":"200","author":"SS Majri","year":"2018","unstructured":"Majri SS, Fritz JM, Villarino AV, Zheng L, Kanellopoulou C, Chaigne-Delalande B, et al. STAT5B: a differential regulator of the life and death of CD4(+) effector memory T cells. J Immunol. 2018;200(1):110\u20138.","journal-title":"J Immunol"},{"issue":"12","key":"790_CR41","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1074\/mcp.M114.041178","volume":"13","author":"MF Jamaluddin","year":"2014","unstructured":"Jamaluddin MF, Bailey UM, Schulz BL. Oligosaccharyltransferase subunits bind polypeptide substrate to locally enhance N-glycosylation. Mol Cell Proteomics. 2014;13(12):3286\u201393.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"790_CR42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1083\/jcb.130.3.567","volume":"130","author":"D Karaoglu","year":"1995","unstructured":"Karaoglu D, Kelleher DJ, Gilmore R. Functional characterization of Ost3p. Loss of the 34-kD subunit of the Saccharomyces cerevisiae oligosaccharyltransferase results in biased underglycosylation of acceptor substrates. J Cell Biol. 1995;130(3):567\u201377.","journal-title":"J Cell Biol"},{"key":"790_CR43","unstructured":"Ravell J, Lenardo M. manuscript in preparation. National Institute of Allergy and Infectious Diseases, National Institutes of Health."},{"issue":"6","key":"790_CR44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MOP.0000000000000156","volume":"26","author":"J Ravell","year":"2014","unstructured":"Ravell J, Chaigne-Delalande B, Lenardo M. X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect. Curr Opin Pediatr. 2014;26(6):713\u20139.","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"790_CR45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481\u201392.","journal-title":"N Engl J Med"},{"issue":"1","key":"790_CR46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","volume":"207","author":"HH Balfour Jr","year":"2013","unstructured":"Balfour HH Jr, Odumade OA, Schmeling DO, Mullan BD, Ed JA, Knight JA, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis. 2013;207(1):80\u20138.","journal-title":"J Infect Dis"},{"issue":"5","key":"790_CR47","doi-asserted-by":"crossref","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","volume":"8","author":"JB Dowd","year":"2013","unstructured":"Dowd JB, et al. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6\u201319, 2003\u20132010. PLoS One. 2013;8(5):e64921.","journal-title":"PLoS One"},{"issue":"4","key":"790_CR48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/ciu342","volume":"59","author":"LM Condon","year":"2014","unstructured":"Condon LM, Cederberg LE, Rabinovitch MD, Liebo RV, Go JC, Delaney AS, et al. Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race\/ethnicity and family environment. Clin Infect Dis. 2014;59(4):501\u20138.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"790_CR49","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.1701467","volume":"200","author":"SK Gotru","year":"2018","unstructured":"Gotru SK, Gil-Pulido J, Beyersdorf N, Diefenbach A, Becker IC, V\u00f6gtle T, et al. Cutting edge: imbalanced Cation homeostasis in MAGT1-deficient B cells Dysregulates B cell development and signaling in mice. J Immunol. 2018;200(8):2529\u201334.","journal-title":"J Immunol"},{"key":"790_CR50","unstructured":"Immuno-Navigator. Available from: https:\/\/genomics.virus.kyoto-u.ac.jp\/immuno-navigator\/."},{"issue":"8","key":"790_CR51","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/ajmg.a.34077","volume":"155A","author":"M Garshasbi","year":"2011","unstructured":"Garshasbi M, Kahrizi K, Hosseini M, Nouri Vahid L, Falah M, Hemmati S, et al. A novel nonsense mutation in TUSC3 is responsible for non-syndromic autosomal recessive mental retardation in a consanguineous Iranian family. Am J Med Genet A. 2011;155A(8):1976\u201380.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"790_CR52","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ajhg.2008.03.018","volume":"82","author":"M Garshasbi","year":"2008","unstructured":"Garshasbi M, Hadavi V, Habibi H, Kahrizi K, Kariminejad R, Behjati F, et al. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. Am J Hum Genet. 2008;82(5):1158\u201364.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"790_CR53","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ajhg.2008.03.021","volume":"82","author":"F Molinari","year":"2008","unstructured":"Molinari F, Foulquier F, Tarpey PS, Morelle W, Boissel S, Teague J, et al. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Am J Hum Genet. 2008;82(5):1150\u20137.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"790_CR54","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ajhg.2013.06.013","volume":"93","author":"A Piton","year":"2013","unstructured":"Piton A, Redin C, Mandel JL. XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. Am J Hum Genet. 2013;93(2):368\u201383.","journal-title":"Am J Hum Genet"},{"issue":"6908","key":"790_CR55","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","volume":"419","author":"V Groh","year":"2002","unstructured":"Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 2002;419(6908):734\u20138.","journal-title":"Nature"},{"issue":"1","key":"790_CR56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20160849","volume":"214","author":"H Abolhassani","year":"2017","unstructured":"Abolhassani H, Edwards ESJ, Ikinciogullari A, Jing H, Borte S, Buggert M, et al. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med. 2017;214(1):91\u2013106.","journal-title":"J Exp Med"},{"key":"790_CR57","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fimmu.2018.01103","volume":"9","author":"S Latour","year":"2018","unstructured":"Latour S, Winter S. Inherited Immunodeficiencies with high predisposition to Epstein-Barr virus-driven Lymphoproliferative diseases. Front Immunol. 2018;9:1103.","journal-title":"Front Immunol"},{"issue":"2","key":"790_CR58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20161846","volume":"214","author":"SG Tangye","year":"2017","unstructured":"Tangye SG, Palendira U, Edwards ES. Human immunity against EBV-lessons from the clinic. J Exp Med. 2017;214(2):269\u201383.","journal-title":"J Exp Med"},{"issue":"13","key":"790_CR59","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","volume":"123","author":"S Price","year":"2014","unstructured":"Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014;123(13):1989\u201399.","journal-title":"Blood"},{"issue":"22","key":"790_CR60","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1182\/blood-2011-07-325217","volume":"118","author":"VK Rao","year":"2011","unstructured":"Rao VK, Oliveira JB. How I treat autoimmune lymphoproliferative syndrome. Blood. 2011;118(22):5741\u201351.","journal-title":"Blood"},{"issue":"22","key":"790_CR61","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011;117(22):5835\u201349.","journal-title":"Blood"},{"issue":"1","key":"790_CR62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10875-018-0578-8","volume":"39","author":"J Hadjadj","year":"2019","unstructured":"Hadjadj J, Guffroy A, Delavaud C, Taieb G, Meyts I, Fresard A, et al. Progressive multifocal leukoencephalopathy in primary Immunodeficiencies. J Clin Immunol. 2019;39(1):55\u201364.","journal-title":"J Clin Immunol"},{"issue":"4","key":"790_CR63","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2009.12.983","volume":"125","author":"I Caminha","year":"2010","unstructured":"Caminha I, Fleisher TA, Hornung RL, Dale JK, Niemela JE, Price S, et al. Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol. 2010;125(4):946\u20139 e6.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00790-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T23:34:33Z","timestamp":1621985673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00790-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00790-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]},"assertion":[{"value":"25 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}